Exicure, Inc. (XCUR)
NASDAQ: XCUR · Real-Time Price · USD
4.180
-0.075 (-1.76%)
At close: Apr 1, 2026, 4:00 PM EDT
4.040
-0.140 (-3.35%)
Pre-market: Apr 2, 2026, 5:03 AM EDT
Exicure Employees
Exicure had 8 employees as of March 31, 2025. The number of employees increased by 1 or 14.29% since the number was last reported on December 31, 2024.
Employees
8
Change
1
Growth
14.29%
Revenue / Employee
n/a
Profits / Employee
-$618,250
Market Cap
26.64M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2025 | 8 | 1 | 14.29% |
| Dec 31, 2024 | 7 | 1 | 16.67% |
| Dec 31, 2023 | 6 | -7 | -53.85% |
| Dec 31, 2022 | 13 | -34 | -72.34% |
| Dec 31, 2021 | 47 | -16 | -25.40% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| IGC Pharma | 70 |
| Kyntra Bio | 34 |
| Senti Biosciences | 34 |
| Plus Therapeutics | 28 |
| Passage Bio | 24 |
| Daré Bioscience | 23 |
| NeuroSense Therapeutics | 17 |
| BriaCell Therapeutics | 16 |
XCUR News
- 7 days ago - Exicure, Inc. Reports Full Year 2025 Financial Results - GlobeNewsWire
- 2 months ago - Exicure Announces Publication in Annals of Hematology Highlighting Rapid Stem Cell Mobilization with Burixafor in Patients with Multiple Myeloma and Lymphoma Undergoing Transplant - GlobeNewsWire
- 2 months ago - Exicure to Present Data from Burixafor Phase 2 Trial at the 2026 Tandem Meetings - GlobeNewsWire
- 4 months ago - Exicure Rally Fueled By Rapid Cell-Boosting Results In Blood Cancer Trial - Benzinga
- 4 months ago - Exicure Presents Positive Topline Phase 2 Data for Burixafor in Multiple Myeloma at 2025 ASH Annual Meeting - GlobeNewsWire
- 5 months ago - Exicure, Inc. Reports Third Quarter 2025 Financial Results - GlobeNewsWire
- 5 months ago - New Burixafor Clinical Data to be Presented as an Oral Presentation at the 2025 ASH Annual Meeting - GlobeNewsWire
- 5 months ago - Halper Sadeh LLC Encourages Exicure, Inc. Shareholders to Contact the Firm to Discuss Their Rights - Business Wire